Healthcare

Liviniti Partners with Mindera Health to Improve Psoriasis Patient Care and Reduce Specialty Pharmacy Spend

Innovative collaboration will improve patient outcomes and cost savings through reduced trial-and-error management of biologic therapiesNatchitoches, Louisiana--(Newsfile Corp. - February…

8 months ago

EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer

Aldrich’s proven commercial, operational and leadership expertise helps position EndoSound for EVS launch and sustainable growthPORTLAND, Ore.--(BUSINESS WIRE)--EndoSound™ Inc., a…

8 months ago

Stone Diagnostics Announces Strategic Partnership With Altus Ace (ACE)

Stone Diagnostics' State-of-the-Art Preventive Diagnostic Testing Platforms Empower ACE Providers to Optimize Patient Outcomes With Preventative Diagnostic Testing SolutionsSANTA ROSA…

8 months ago

Biotricity Receives Health Canada Clearance for Biotres

Well Positioned to Enter US $1.56 Billion Canadian Cardiology Devices MarketREDWOOD CITY, CA / ACCESSWIRE / February 29, 2024 /…

8 months ago

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in…

8 months ago

Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases

First patients in clinical study at Beilinson Hospital were scanned with the Nanox.ARC, a stationary X-ray system that produces 3D…

8 months ago

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

SOLANA BEACH, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell,…

8 months ago

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

$60 million financing upfront with up to an additional $64.2 million tied to exercise of milestone-driven warrants Upfront net proceeds…

8 months ago

VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update

2023 was a transformative year for VYNE, marked by the achievement of clinical proof-of-concept for VYN201 in vitiligo and a successful…

8 months ago

OneMedNet Signs New Network Partnership Agreement with One of the Largest Private Hospital Operators in U.S.

~ Partnership Will Significantly Expand Depth and Diversity of Real World Data Availability for Life Science Innovation ~MINNEAPOLIS, Feb. 29,…

8 months ago